Valneva Reports First Quarter 2024 Financial Results and Provides Corporate Updates

07.05.2024 - Valneva Reports First Quarter 2024 Financial Results and Provides Corporate Updates Q1 financial highlights Total revenues of €32.8 million, including sales of €32.1 million, on track to meet anticipated full year guidance ...

Related Keywords

Brazil ,United Kingdom ,United States ,France ,Canada ,Brazilian ,Scotland ,Canadian ,French ,Rabipur Rabavert ,Joshua Drumm ,Instituto Butantan ,Fda Tropical Disease Priority Review Voucher Program ,Coalition For Epidemic Preparedness Innovations ,Pfizer ,Us Centers For Disease ,Global Communications ,Us Advisory Committee On Immunization Practices ,Deerfield Management Company ,Exchange Commission ,Third Party ,Priority Review Voucher ,Euronext Paris ,Financial Reports ,Chief Financial Officer ,Lyme Phase ,Disease Control ,European Medicine Agency ,Medicinal Products ,Human Use ,Epidemic Preparedness Innovations ,Fast Track ,Against Lyme ,Biologic License Application ,Marketing Authorization Application ,Southeast Asia ,Pacific Islands ,Prescribing Information ,European Investor ,Global Investor ,Valneva Aktie ,